Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxd2
|
ENSMUSG00000055210.3 | forkhead box D2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_114907971_114908867 | Foxd2 | 454 | 0.612118 | 0.21 | 1.1e-01 | Click! |
chr4_114905731_114906737 | Foxd2 | 2639 | 0.177730 | -0.06 | 6.3e-01 | Click! |
chr4_114907053_114907204 | Foxd2 | 1745 | 0.236508 | -0.06 | 6.5e-01 | Click! |
chr4_114906817_114906968 | Foxd2 | 1981 | 0.215217 | 0.04 | 7.7e-01 | Click! |
chr4_114907257_114907947 | Foxd2 | 1271 | 0.304327 | 0.02 | 8.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_59095360_59096062 | 4.39 |
Mia2 |
MIA SH3 domain ER export factor 2 |
88 |
0.93 |
chr18_11049995_11051717 | 4.31 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr19_55102740_55102891 | 3.90 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
276 |
0.91 |
chr7_106528440_106529206 | 3.72 |
Gm8995 |
predicted gene 8995 |
17152 |
0.19 |
chr10_5287995_5289689 | 3.65 |
Gm23573 |
predicted gene, 23573 |
68331 |
0.12 |
chr15_41751298_41752572 | 3.59 |
Oxr1 |
oxidation resistance 1 |
234 |
0.95 |
chr10_99912846_99913873 | 3.57 |
Gm47579 |
predicted gene, 47579 |
47339 |
0.13 |
chr8_45886169_45886353 | 3.51 |
Pdlim3 |
PDZ and LIM domain 3 |
741 |
0.57 |
chr6_137935280_137935834 | 3.35 |
Gm24308 |
predicted gene, 24308 |
15586 |
0.26 |
chr9_77044031_77044308 | 3.33 |
Tinag |
tubulointerstitial nephritis antigen |
1580 |
0.34 |
chr10_116275477_116276105 | 3.28 |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
241 |
0.93 |
chr15_98606691_98607532 | 3.15 |
Adcy6 |
adenylate cyclase 6 |
522 |
0.61 |
chr5_101700539_101700765 | 3.11 |
9430085M18Rik |
RIKEN cDNA 9430085M18 gene |
2934 |
0.22 |
chrX_82950582_82950733 | 3.10 |
Dmd |
dystrophin, muscular dystrophy |
1754 |
0.53 |
chr3_60529662_60530216 | 3.08 |
Mbnl1 |
muscleblind like splicing factor 1 |
308 |
0.91 |
chr1_184729275_184729496 | 3.06 |
Hlx |
H2.0-like homeobox |
2213 |
0.23 |
chr17_79261126_79261277 | 2.93 |
Gm5230 |
predicted gene 5230 |
3152 |
0.32 |
chr17_75437948_75438432 | 2.87 |
Rasgrp3 |
RAS, guanyl releasing protein 3 |
2264 |
0.4 |
chr18_69428544_69429048 | 2.82 |
Tcf4 |
transcription factor 4 |
12899 |
0.28 |
chr2_114055154_114055663 | 2.80 |
C130080G10Rik |
RIKEN cDNA C130080G10 gene |
161 |
0.93 |
chr1_184675496_184676152 | 2.79 |
Gm38358 |
predicted gene, 38358 |
19210 |
0.14 |
chr3_145101984_145102292 | 2.77 |
Clca2 |
chloride channel accessory 2 |
2695 |
0.28 |
chr8_41015082_41015919 | 2.76 |
Mtus1 |
mitochondrial tumor suppressor 1 |
820 |
0.53 |
chr10_53338934_53339122 | 2.73 |
Pln |
phospholamban |
1323 |
0.32 |
chr8_32004165_32004671 | 2.72 |
Nrg1 |
neuregulin 1 |
4688 |
0.33 |
chr6_99275359_99276069 | 2.68 |
Foxp1 |
forkhead box P1 |
9182 |
0.29 |
chr18_43736152_43737245 | 2.66 |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
859 |
0.6 |
chr6_129183729_129184848 | 2.66 |
Clec2d |
C-type lectin domain family 2, member d |
3673 |
0.14 |
chr11_83849571_83850989 | 2.65 |
Hnf1b |
HNF1 homeobox B |
217 |
0.83 |
chr16_87611369_87612106 | 2.61 |
Gm22808 |
predicted gene, 22808 |
9383 |
0.19 |
chr5_105139072_105139612 | 2.60 |
Gbp9 |
guanylate-binding protein 9 |
197 |
0.33 |
chr9_60795900_60796901 | 2.58 |
Uaca |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
1775 |
0.35 |
chr12_63552410_63552561 | 2.58 |
Gm48417 |
predicted gene, 48417 |
19378 |
0.25 |
chrX_82950239_82950524 | 2.57 |
Dmd |
dystrophin, muscular dystrophy |
1478 |
0.58 |
chr10_58394969_58395625 | 2.56 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
909 |
0.6 |
chr4_118487482_118487969 | 2.55 |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
2030 |
0.19 |
chr10_69321361_69322099 | 2.55 |
Gm40685 |
predicted gene, 40685 |
9591 |
0.17 |
chr11_22154605_22154920 | 2.52 |
Ehbp1 |
EH domain binding protein 1 |
16648 |
0.27 |
chr17_47832362_47834525 | 2.50 |
Mdfi |
MyoD family inhibitor |
152 |
0.93 |
chr1_43195232_43195467 | 2.45 |
Fhl2 |
four and a half LIM domains 2 |
1412 |
0.4 |
chr10_5596272_5596423 | 2.44 |
Myct1 |
myc target 1 |
2572 |
0.33 |
chr13_98691032_98691862 | 2.42 |
Tmem171 |
transmembrane protein 171 |
3321 |
0.18 |
chr14_101839786_101841002 | 2.41 |
Lmo7 |
LIM domain only 7 |
97 |
0.98 |
chr7_89405888_89406433 | 2.40 |
Fzd4 |
frizzled class receptor 4 |
1805 |
0.24 |
chr1_55136173_55136344 | 2.39 |
Mob4 |
MOB family member 4, phocein |
4932 |
0.13 |
chr10_116276295_116276851 | 2.38 |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
1023 |
0.54 |
chr2_160472979_160473873 | 2.35 |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
106361 |
0.06 |
chr5_102768473_102769767 | 2.32 |
Arhgap24 |
Rho GTPase activating protein 24 |
349 |
0.93 |
chr9_101196762_101197254 | 2.30 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
1843 |
0.24 |
chr15_8967409_8968940 | 2.30 |
Ranbp3l |
RAN binding protein 3-like |
172 |
0.96 |
chr15_53113642_53113793 | 2.29 |
Ext1 |
exostosin glycosyltransferase 1 |
5849 |
0.34 |
chr13_46421773_46422087 | 2.29 |
Rbm24 |
RNA binding motif protein 24 |
108 |
0.98 |
chr9_105520039_105521535 | 2.27 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr2_148043571_148045987 | 2.26 |
Foxa2 |
forkhead box A2 |
685 |
0.65 |
chr19_20389423_20390852 | 2.26 |
Anxa1 |
annexin A1 |
514 |
0.81 |
chr6_37645617_37646179 | 2.26 |
Ybx1-ps2 |
Y box protein 1, pseudogene 2 |
41297 |
0.18 |
chrX_120591703_120591854 | 2.25 |
Gm14930 |
predicted gene 14930 |
149092 |
0.04 |
chr7_81566287_81566808 | 2.25 |
Fsd2 |
fibronectin type III and SPRY domain containing 2 |
397 |
0.74 |
chr12_62664112_62664263 | 2.25 |
Spanxn4 |
SPANX family, member N4 |
23635 |
0.16 |
chr17_81733494_81733965 | 2.23 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
4648 |
0.31 |
chr12_31267815_31268221 | 2.22 |
Lamb1 |
laminin B1 |
2721 |
0.18 |
chr3_138279058_138279275 | 2.20 |
Adh1 |
alcohol dehydrogenase 1 (class I) |
1515 |
0.28 |
chr6_97929540_97930859 | 2.20 |
Mitf |
melanogenesis associated transcription factor |
400 |
0.89 |
chr7_28959414_28959929 | 2.18 |
Actn4 |
actinin alpha 4 |
2552 |
0.16 |
chr14_110753664_110754027 | 2.18 |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
1304 |
0.42 |
chr6_142570795_142570980 | 2.12 |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
484 |
0.82 |
chr6_42352223_42352654 | 2.09 |
Zyx |
zyxin |
1040 |
0.28 |
chr8_83738506_83738670 | 2.09 |
Adgre5 |
adhesion G protein-coupled receptor E5 |
2581 |
0.17 |
chr12_37112722_37113009 | 2.08 |
Meox2 |
mesenchyme homeobox 2 |
4325 |
0.22 |
chrX_106840356_106840805 | 2.08 |
Rtl3 |
retrotransposon Gag like 3 |
64 |
0.97 |
chr17_75180734_75181322 | 2.08 |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
2117 |
0.38 |
chr15_11455557_11455708 | 2.08 |
Tars |
threonyl-tRNA synthetase |
55967 |
0.14 |
chr3_57293411_57293693 | 2.05 |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
151 |
0.96 |
chr17_88628874_88630550 | 2.05 |
Ston1 |
stonin 1 |
2348 |
0.25 |
chr9_79976568_79977294 | 2.05 |
Filip1 |
filamin A interacting protein 1 |
728 |
0.66 |
chr2_160620140_160620291 | 2.05 |
Gm14221 |
predicted gene 14221 |
244 |
0.91 |
chr1_112456627_112457016 | 2.04 |
Gm22331 |
predicted gene, 22331 |
11090 |
0.28 |
chr18_61954762_61955556 | 2.04 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
2075 |
0.33 |
chr15_3580312_3581004 | 2.03 |
Ghr |
growth hormone receptor |
1184 |
0.57 |
chr6_48746767_48747146 | 2.03 |
Gimap5 |
GTPase, IMAP family member 5 |
657 |
0.42 |
chr12_57544414_57545119 | 2.01 |
Foxa1 |
forkhead box A1 |
1355 |
0.37 |
chrX_136144337_136144557 | 2.01 |
Bex4 |
brain expressed X-linked 4 |
5451 |
0.13 |
chr12_35533032_35533561 | 2.00 |
Gm48236 |
predicted gene, 48236 |
1125 |
0.37 |
chr10_5594267_5594984 | 1.99 |
Myct1 |
myc target 1 |
850 |
0.67 |
chr11_30195109_30195350 | 1.98 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
3028 |
0.33 |
chr5_65863575_65864152 | 1.96 |
Rhoh |
ras homolog family member H |
245 |
0.86 |
chr12_98683337_98683705 | 1.95 |
Ptpn21 |
protein tyrosine phosphatase, non-receptor type 21 |
229 |
0.9 |
chr17_43362301_43362937 | 1.93 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
2168 |
0.39 |
chr10_115817324_115818606 | 1.89 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr15_3271737_3272448 | 1.87 |
Selenop |
selenoprotein P |
7 |
0.98 |
chr16_91548558_91548730 | 1.86 |
Ifngr2 |
interferon gamma receptor 2 |
1497 |
0.24 |
chr4_8237536_8238080 | 1.85 |
Car8 |
carbonic anhydrase 8 |
1233 |
0.46 |
chr3_146179676_146180078 | 1.84 |
Mcoln2 |
mucolipin 2 |
10488 |
0.17 |
chr15_51274333_51274786 | 1.83 |
Gm19303 |
predicted gene, 19303 |
121051 |
0.06 |
chr2_110360491_110361293 | 1.83 |
Fibin |
fin bud initiation factor homolog (zebrafish) |
2291 |
0.34 |
chrX_13469421_13469615 | 1.82 |
Nyx |
nyctalopin |
3408 |
0.24 |
chr16_26103797_26103994 | 1.82 |
P3h2 |
prolyl 3-hydroxylase 2 |
1889 |
0.46 |
chr19_34552129_34552396 | 1.80 |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
1552 |
0.26 |
chr12_37110777_37111603 | 1.77 |
Meox2 |
mesenchyme homeobox 2 |
2650 |
0.27 |
chrX_56734932_56735173 | 1.76 |
Fhl1 |
four and a half LIM domains 1 |
2923 |
0.22 |
chr7_133781874_133782457 | 1.75 |
Dhx32 |
DEAH (Asp-Glu-Ala-His) box polypeptide 32 |
561 |
0.7 |
chr7_143086048_143086508 | 1.75 |
Trpm5 |
transient receptor potential cation channel, subfamily M, member 5 |
851 |
0.44 |
chr4_138943479_138943730 | 1.75 |
Rnf186 |
ring finger protein 186 |
23508 |
0.12 |
chr1_66895911_66896062 | 1.74 |
Gm25832 |
predicted gene, 25832 |
29189 |
0.09 |
chr4_53878509_53878668 | 1.74 |
Gm12468 |
predicted gene 12468 |
663 |
0.67 |
chrX_6580425_6580576 | 1.73 |
Shroom4 |
shroom family member 4 |
3214 |
0.38 |
chr14_101888217_101888439 | 1.73 |
Lmo7 |
LIM domain only 7 |
4209 |
0.32 |
chr6_129180573_129181444 | 1.73 |
Clec2d |
C-type lectin domain family 2, member d |
393 |
0.77 |
chr10_30838746_30839745 | 1.73 |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
2770 |
0.24 |
chr4_11705100_11705674 | 1.72 |
Gem |
GTP binding protein (gene overexpressed in skeletal muscle) |
420 |
0.85 |
chr4_84768134_84768574 | 1.71 |
Gm12415 |
predicted gene 12415 |
26879 |
0.21 |
chr9_56415805_56415956 | 1.71 |
Gm36940 |
predicted gene, 36940 |
186 |
0.91 |
chr17_35821748_35823149 | 1.71 |
Ier3 |
immediate early response 3 |
764 |
0.28 |
chr8_47763533_47764764 | 1.69 |
Gm45824 |
predicted gene 45824 |
1977 |
0.21 |
chr13_48543356_48543507 | 1.69 |
Gm37238 |
predicted gene, 37238 |
1602 |
0.19 |
chr16_44015370_44016774 | 1.69 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr8_11309999_11311023 | 1.68 |
Col4a1 |
collagen, type IV, alpha 1 |
2178 |
0.24 |
chr10_34432217_34432400 | 1.66 |
Nt5dc1 |
5'-nucleotidase domain containing 1 |
13756 |
0.19 |
chr10_97479376_97480642 | 1.65 |
Dcn |
decorin |
400 |
0.88 |
chr3_127763027_127763314 | 1.64 |
Alpk1 |
alpha-kinase 1 |
17320 |
0.1 |
chr2_166030364_166031781 | 1.63 |
Ncoa3 |
nuclear receptor coactivator 3 |
16846 |
0.15 |
chr5_43869783_43870400 | 1.63 |
Cd38 |
CD38 antigen |
1231 |
0.3 |
chr14_110753127_110753447 | 1.62 |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
1862 |
0.32 |
chr6_137570111_137570964 | 1.60 |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
222 |
0.95 |
chr12_69447750_69448552 | 1.60 |
5830428M24Rik |
RIKEN cDNA 5830428M24 gene |
19241 |
0.14 |
chr2_178411563_178412733 | 1.59 |
Ppp1r3d |
protein phosphatase 1, regulatory subunit 3D |
2324 |
0.22 |
chr4_139580377_139581854 | 1.58 |
Iffo2 |
intermediate filament family orphan 2 |
6395 |
0.15 |
chr4_45965494_45966277 | 1.57 |
Tdrd7 |
tudor domain containing 7 |
551 |
0.79 |
chr8_41039372_41040105 | 1.57 |
Gm16192 |
predicted gene 16192 |
18 |
0.65 |
chr2_148436626_148436927 | 1.57 |
Cd93 |
CD93 antigen |
6787 |
0.16 |
chr1_155809619_155810012 | 1.56 |
Qsox1 |
quiescin Q6 sulfhydryl oxidase 1 |
3005 |
0.17 |
chr18_90002590_90002741 | 1.56 |
Gm6173 |
predicted gene 6173 |
16414 |
0.25 |
chr12_40471563_40472715 | 1.56 |
Dock4 |
dedicator of cytokinesis 4 |
25803 |
0.2 |
chr6_14905914_14906199 | 1.55 |
Foxp2 |
forkhead box P2 |
2599 |
0.43 |
chr9_32343029_32343609 | 1.55 |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
918 |
0.54 |
chr5_119804344_119805024 | 1.55 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
2983 |
0.24 |
chr2_35431827_35432962 | 1.54 |
Ggta1 |
glycoprotein galactosyltransferase alpha 1, 3 |
239 |
0.89 |
chr4_152097860_152098609 | 1.53 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
1515 |
0.28 |
chr16_57552178_57552349 | 1.53 |
Filip1l |
filamin A interacting protein 1-like |
3021 |
0.33 |
chr10_71024642_71025620 | 1.52 |
Gm48025 |
predicted gene, 48025 |
32091 |
0.14 |
chr10_99618893_99619600 | 1.52 |
Gm20110 |
predicted gene, 20110 |
10075 |
0.17 |
chr3_85195301_85195774 | 1.52 |
Gm38313 |
predicted gene, 38313 |
910 |
0.67 |
chr13_103173948_103174142 | 1.51 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
2516 |
0.34 |
chrX_157700177_157700800 | 1.50 |
Smpx |
small muscle protein, X-linked |
1228 |
0.39 |
chr9_119052293_119053778 | 1.50 |
Vill |
villin-like |
170 |
0.93 |
chr17_88627411_88628033 | 1.49 |
Ston1 |
stonin 1 |
358 |
0.85 |
chr8_33903951_33904228 | 1.49 |
Rbpms |
RNA binding protein gene with multiple splicing |
12325 |
0.17 |
chr1_164455819_164456603 | 1.49 |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
1811 |
0.27 |
chr3_68676477_68677404 | 1.48 |
Il12a |
interleukin 12a |
13704 |
0.19 |
chr3_129836696_129837785 | 1.48 |
Cfi |
complement component factor i |
503 |
0.7 |
chr7_46029818_46030744 | 1.48 |
Abcc6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
21 |
0.96 |
chr2_170075358_170075771 | 1.47 |
Zfp217 |
zinc finger protein 217 |
55656 |
0.15 |
chr19_20602564_20602913 | 1.46 |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
777 |
0.68 |
chr6_99095299_99096526 | 1.46 |
Foxp1 |
forkhead box P1 |
293 |
0.93 |
chr5_107961024_107961268 | 1.45 |
Dipk1a |
divergent protein kinase domain 1A |
11852 |
0.13 |
chr2_70923076_70923642 | 1.44 |
Gm13632 |
predicted gene 13632 |
45530 |
0.13 |
chr15_40656769_40657228 | 1.44 |
Zfpm2 |
zinc finger protein, multitype 2 |
1647 |
0.51 |
chr8_57315271_57316273 | 1.44 |
Hand2os1 |
Hand2, opposite strand 1 |
62 |
0.96 |
chr2_60939895_60940920 | 1.43 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22785 |
0.21 |
chr13_4192201_4192380 | 1.43 |
Akr1c13 |
aldo-keto reductase family 1, member C13 |
1106 |
0.4 |
chr2_170002872_170003567 | 1.43 |
AY702102 |
cDNA sequence AY702102 |
40032 |
0.2 |
chr17_27058309_27058493 | 1.43 |
Itpr3 |
inositol 1,4,5-triphosphate receptor 3 |
1097 |
0.32 |
chr13_87192370_87192521 | 1.42 |
Gm47642 |
predicted gene, 47642 |
42149 |
0.21 |
chr5_20897783_20897952 | 1.42 |
Tmem60 |
transmembrane protein 60 |
15360 |
0.15 |
chr13_38958254_38958654 | 1.41 |
Slc35b3 |
solute carrier family 35, member B3 |
2026 |
0.28 |
chrX_74248072_74248576 | 1.41 |
Flna |
filamin, alpha |
1496 |
0.18 |
chr16_57550746_57551177 | 1.41 |
Filip1l |
filamin A interacting protein 1-like |
1719 |
0.45 |
chr11_96316025_96316970 | 1.41 |
Mir10a |
microRNA 10a |
668 |
0.4 |
chr5_53706072_53707121 | 1.40 |
Cckar |
cholecystokinin A receptor |
657 |
0.78 |
chr18_21821900_21822125 | 1.40 |
Klhl14 |
kelch-like 14 |
167294 |
0.04 |
chr9_69457683_69458529 | 1.39 |
Mir3109 |
microRNA 3109 |
1162 |
0.34 |
chr16_19981596_19982182 | 1.39 |
Klhl6 |
kelch-like 6 |
1041 |
0.58 |
chr2_17459201_17459498 | 1.38 |
Nebl |
nebulette |
1272 |
0.59 |
chr17_67351548_67352402 | 1.38 |
Ptprm |
protein tyrosine phosphatase, receptor type, M |
2098 |
0.47 |
chr3_151762523_151763341 | 1.37 |
Ifi44l |
interferon-induced protein 44 like |
40 |
0.98 |
chr7_68917284_68917934 | 1.37 |
Gm34664 |
predicted gene, 34664 |
1593 |
0.45 |
chr4_88956102_88956253 | 1.36 |
Gm49890 |
predicted gene, 49890 |
17656 |
0.11 |
chr1_188904008_188904301 | 1.36 |
Ush2a |
usherin |
49590 |
0.15 |
chr16_19982574_19983084 | 1.36 |
Klhl6 |
kelch-like 6 |
101 |
0.97 |
chr10_52194408_52194559 | 1.36 |
Ros1 |
Ros1 proto-oncogene |
473 |
0.78 |
chr9_71590180_71590500 | 1.36 |
Myzap |
myocardial zonula adherens protein |
1925 |
0.34 |
chr18_54452409_54453689 | 1.36 |
Gm50361 |
predicted gene, 50361 |
23716 |
0.19 |
chr6_71261498_71261790 | 1.36 |
Smyd1 |
SET and MYND domain containing 1 |
588 |
0.59 |
chr6_6101981_6102393 | 1.35 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
6984 |
0.28 |
chr5_104114806_104115117 | 1.35 |
Gm26703 |
predicted gene, 26703 |
1073 |
0.32 |
chr3_129803440_129803831 | 1.35 |
Lrit3 |
leucine-rich repeat, immunoglobulin-like and transmembrane domains 3 |
395 |
0.78 |
chr2_166806459_166806614 | 1.35 |
Arfgef2 |
ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) |
948 |
0.54 |
chr2_12298558_12298709 | 1.34 |
E030013I19Rik |
RIKEN cDNA E030013I19 gene |
2313 |
0.26 |
chr3_123984120_123984365 | 1.34 |
Gm15399 |
predicted gene 15399 |
862 |
0.74 |
chr18_70804952_70805557 | 1.34 |
Gm21046 |
predicted gene, 21046 |
23367 |
0.2 |
chr4_102571735_102572508 | 1.34 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
2026 |
0.47 |
chr1_13659216_13659367 | 1.34 |
Lactb2 |
lactamase, beta 2 |
1255 |
0.43 |
chr6_22493750_22494021 | 1.34 |
Gm43630 |
predicted gene 43630 |
129033 |
0.05 |
chr1_57436269_57437534 | 1.34 |
Gm22371 |
predicted gene, 22371 |
14528 |
0.14 |
chr18_87961648_87961998 | 1.33 |
Gm24987 |
predicted gene, 24987 |
36259 |
0.21 |
chr11_85887314_85887643 | 1.33 |
Tbx4 |
T-box 4 |
1056 |
0.49 |
chr2_138277835_138280637 | 1.33 |
Btbd3 |
BTB (POZ) domain containing 3 |
743 |
0.81 |
chr2_101624764_101625056 | 1.33 |
Rag2 |
recombination activating gene 2 |
164 |
0.94 |
chr6_99263557_99264940 | 1.33 |
Foxp1 |
forkhead box P1 |
2267 |
0.43 |
chr9_21227741_21228074 | 1.33 |
Gm16754 |
predicted gene, 16754 |
2504 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.9 | 2.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.8 | 2.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.8 | 3.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 4.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.7 | 3.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 1.4 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.7 | 2.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.6 | 1.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.6 | 1.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 1.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.6 | 1.8 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.6 | 2.3 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.5 | 1.5 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.5 | 1.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 1.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 1.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 2.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 2.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.4 | 1.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 1.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 1.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 1.3 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.3 | 1.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 0.9 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 1.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 1.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.3 | 0.9 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 2.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 1.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 1.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 0.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.3 | 0.8 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 0.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 1.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 1.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 1.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.4 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.2 | 0.7 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.2 | 0.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.9 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.2 | 0.6 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 2.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 4.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 1.5 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.2 | 1.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.6 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.2 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.9 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 5.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 2.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.9 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 0.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.2 | 0.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 1.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 1.6 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.6 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 2.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.9 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.2 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.2 | 0.3 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.2 | 0.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 3.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 1.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 2.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 1.3 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 1.6 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 0.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.4 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.2 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.5 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.4 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 0.2 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.2 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.7 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.8 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.6 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 1.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.2 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 0.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 1.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 1.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.1 | 0.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.1 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 1.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 1.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.6 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 1.1 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 1.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.1 | 3.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.2 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.2 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.1 | 0.2 | GO:0051794 | regulation of catagen(GO:0051794) |
0.1 | 0.1 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 2.8 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.1 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.1 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.1 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.2 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 1.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.8 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.3 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.1 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.1 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.8 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.1 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.1 | GO:0051464 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.1 | GO:0003130 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.1 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 1.3 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.2 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.1 | 0.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.1 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.2 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.2 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.6 | GO:0060045 | positive regulation of cardiac muscle cell proliferation(GO:0060045) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.2 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.1 | 0.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 1.9 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:2000064 | regulation of cortisol biosynthetic process(GO:2000064) |
0.1 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.5 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.2 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.6 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 1.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.0 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.0 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.4 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 1.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.1 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.0 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.4 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.0 | 0.0 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.2 | GO:0036491 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.0 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 1.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 1.0 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.0 | 0.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.3 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.0 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.0 | 0.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.4 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.0 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.0 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 1.3 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.4 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.1 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.0 | 0.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0071947 | protein K29-linked deubiquitination(GO:0035523) protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.1 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.0 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.0 | 0.2 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.9 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.2 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.0 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.0 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.0 | GO:0048382 | mesendoderm development(GO:0048382) |
0.0 | 0.2 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.4 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.6 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.0 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.0 | 0.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.7 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.0 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
0.0 | 0.2 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.0 | 0.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.0 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.0 | 0.2 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.1 | GO:0050904 | diapedesis(GO:0050904) |
0.0 | 1.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.0 | 0.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.1 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.3 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.9 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.4 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.0 | 0.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.0 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.0 | 0.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.2 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.0 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.1 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.0 | 0.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.0 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.7 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.0 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.0 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.0 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.4 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 0.0 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.0 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.0 | 0.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.0 | 0.0 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.0 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.3 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.0 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.0 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.0 | 0.0 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.0 | 0.2 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.0 | 0.1 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.0 | 0.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.0 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.1 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 1.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.0 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.0 | GO:1902866 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) tetrahydrofolate biosynthetic process(GO:0046654) |
0.0 | 0.0 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.5 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.0 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.2 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.0 | 0.0 | GO:0070989 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.0 | 0.2 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.0 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.0 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.0 | 0.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.0 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.9 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.0 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.2 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.1 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.2 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.0 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.0 | 0.0 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.0 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.0 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.0 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.0 | 0.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.1 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.0 | GO:0060264 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.0 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 1.1 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.3 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 4.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 1.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.3 | 4.4 | GO:0031430 | M band(GO:0031430) |
0.3 | 0.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 2.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 3.6 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 0.9 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.2 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 1.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 3.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 5.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 1.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 2.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 1.3 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 2.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.4 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 5.5 | GO:0031674 | I band(GO:0031674) |
0.1 | 1.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 2.3 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 1.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 3.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 3.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.0 | 1.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 1.3 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.4 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 2.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.1 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 1.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 3.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 1.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 6.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 1.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.9 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 2.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.5 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 1.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 1.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 2.8 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.0 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.0 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.0 | GO:0044449 | contractile fiber part(GO:0044449) |
0.0 | 0.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.2 | 3.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 2.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.6 | 1.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.5 | 2.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 1.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 2.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 5.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 1.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 0.9 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 0.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 2.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 0.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 3.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 5.1 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.3 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 2.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 1.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 9.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 1.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 1.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.8 | GO:0034865 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 1.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 1.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 3.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 2.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.4 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.8 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 2.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0034912 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 2.8 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.1 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 4.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.0 | 0.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.0 | 1.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 4.7 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 3.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 1.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 3.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.0 | 0.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.4 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.6 | GO:0043713 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 4.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 2.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.0 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 1.0 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 1.1 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.6 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.8 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 6.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 3.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 8.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 3.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 2.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 4.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 4.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 1.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 4.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 2.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 13.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 2.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 4.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 5.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 1.5 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 1.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.0 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |